Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Chesler

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Nature Reviews. Cancer|August 6, 2014
Paraneoplasia, cancer development and immunity: what are the connections?Louis Chesler
Journal of Pediatric Hematology/Oncology|November 20, 2002
Use of tissue plasminogen activator (rt-PA) in young children with cancer and dysfunctional central venous cathetersLouis Chesler, James H Feusner
Seminars in Cancer Biology|October 1, 2011
Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastomaLouis Chesler, William A Weiss
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Targeting MYCN and ALK in resistant and relapsing neuroblastomaElizabeth R Tucker, Evon Poon, Louis Chesler
Frontiers in Oncology|July 1, 2021
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges AheadSumana Shrestha, Alaide Morcavallo, Chiara Gorrini, et al.
Cancer Research|July 1, 2015
Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric ClinicElizabeth R Tucker, Laura S Danielson, Paolo Innocenti, et al.
Journal of Personalized Medicine|April 3, 2021
The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with NeuroblastomaElizabeth R Tucker, Sally George, Paola Angelini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALKGiuseppe Barone, John Anderson, Andrew D J Pearson, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Preclinical drug development for childhood cancerLucas Moreno, Louis Chesler, Darren Hargrave, et al.
Frontiers in Pediatrics|December 5, 2022
Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerationsReda Stankunaite, Lynley V Marshall, Fernando Carceller, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Nature Reviews. Cancer|August 6, 2014
Paraneoplasia, cancer development and immunity: what are the connections?Louis Chesler
Journal of Pediatric Hematology/Oncology|November 20, 2002
Use of tissue plasminogen activator (rt-PA) in young children with cancer and dysfunctional central venous cathetersLouis Chesler, James H Feusner
Seminars in Cancer Biology|October 1, 2011
Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastomaLouis Chesler, William A Weiss
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Targeting MYCN and ALK in resistant and relapsing neuroblastomaElizabeth R Tucker, Evon Poon, Louis Chesler
Frontiers in Oncology|July 1, 2021
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges AheadSumana Shrestha, Alaide Morcavallo, Chiara Gorrini, et al.
Cancer Research|July 1, 2015
Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric ClinicElizabeth R Tucker, Laura S Danielson, Paolo Innocenti, et al.
Journal of Personalized Medicine|April 3, 2021
The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with NeuroblastomaElizabeth R Tucker, Sally George, Paola Angelini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALKGiuseppe Barone, John Anderson, Andrew D J Pearson, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Preclinical drug development for childhood cancerLucas Moreno, Louis Chesler, Darren Hargrave, et al.
Frontiers in Pediatrics|December 5, 2022
Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerationsReda Stankunaite, Lynley V Marshall, Fernando Carceller, et al.
Pageof 12